Planned British DNA database could boost drug R&D

12/10/2012 | Financial Times (tiered subscription model) · Reuters

The British government has allotted $160 million to create a genome database of as many as 100,000 patients with cancer and rare conditions over the next three to five years. The project could change the way complex illnesses are diagnosed and treated as well as enhance the discovery and development of novel drugs, and it allow researchers to work with data from the National Health Service, Prime Minister David Cameron said.

View Full Article in:

Financial Times (tiered subscription model) · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ